About A&A Biotechnology
A&A Biotechnology is a company based in Gdansk (Poland) founded in 1993 by Adam Burkiewicz and Amanda Hall-Frasure.. A&A Biotechnology offers products and services including MagnifiQ™ automatic isolation, DNA purification, RNA purification, PCR and reverse transcription, and Enzymes. A&A Biotechnology operates in a competitive market with competitors including ArcherDX, Qiagen, Devyser, DxTerity and PredictImmune, among others.
- Headquarter Gdansk, Poland
- Founders Adam Burkiewicz, Amanda Hall-Frasure
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$367.39 K (USD), Grant
Apr 01, 2016
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of A&A Biotechnology
A&A Biotechnology offers a comprehensive portfolio of products and services, including MagnifiQ™ automatic isolation, DNA purification, RNA purification, PCR and reverse transcription, and Enzymes. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
System for automatic isolation in molecular biology applications
Kits for purifying DNA from various samples
Tools for RNA extraction and purification processes
Reagents for polymerase chain reaction and transcription
Various enzymes for molecular and protein research
Funding Insights of A&A Biotechnology
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $367,386
-
First Round
First Round
(04 Jan 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2016 | Amount | Grant - A&A Biotechnology | Valuation |
investors |
|
| Jan, 2016 | Amount | Grant - A&A Biotechnology | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in A&A Biotechnology
A&A Biotechnology has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by A&A Biotechnology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AA Biotechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
A&A Biotechnology Comparisons
Competitors of A&A Biotechnology
A&A Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, Qiagen, Devyser, DxTerity and PredictImmune, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| domain | founded_year | HQ Location |
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
|
|
| domain | founded_year | HQ Location |
Provider of a direct-to-consumer, non-clinical genetic tests
|
|
| domain | founded_year | HQ Location |
Tools for diagnosing immune-mediated inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Manufacturer of specialist molecular biology analytical instruments and reagents
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about A&A Biotechnology
When was A&A Biotechnology founded?
A&A Biotechnology was founded in 1993 and raised its 1st funding round 23 years after it was founded.
Where is A&A Biotechnology located?
A&A Biotechnology is headquartered in Gdansk, Poland. It is registered at Gdansk, Pomeranian Voivodeship, Poland.
Who is the current CEO of A&A Biotechnology?
Adam Burkiewicz is the current CEO of A&A Biotechnology. They have also founded this company.
What does A&A Biotechnology do?
Provider of genomic-based products for the life science industry. It offers offer includes DNA and RNA isolation kits, PCR and reverse transcription reagents, cloning and transformation reagents, molecular biology reagents and services.
Who are the top competitors of A&A Biotechnology?
What products or services does A&A Biotechnology offer?
A&A Biotechnology offers MagnifiQ™ automatic isolation, DNA purification, RNA purification, PCR and reverse transcription, and Enzymes.
Who are A&A Biotechnology's investors?
A&A Biotechnology has 1 investor. Key investors include European Union.